Literature DB >> 16300813

Individual contributions of the human metapneumovirus F, G, and SH surface glycoproteins to the induction of neutralizing antibodies and protective immunity.

Mario H Skiadopoulos1, Stéphane Biacchesi, Ursula J Buchholz, Emérito Amaro-Carambot, Sonja R Surman, Peter L Collins, Brian R Murphy.   

Abstract

We evaluated the individual contributions of the three surface glycoproteins of human metapneumovirus (HMPV), namely the fusion F, attachment G, and small hydrophobic SH proteins, to the induction of serum HMPV-binding antibodies, serum HMPV-neutralizing antibodies, and protective immunity. Using reverse genetics, each HMPV protein was expressed individually from an added gene in recombinant human parainfluenza virus type 1 (rHPIV1) and used to infect hamsters once or twice by the intranasal route. The F protein was highly immunogenic and protective, whereas G and SH were only weakly or negligibly immunogenic and protective, respectively. Thus, in contrast to other paramyxoviruses, the HMPV attachment G protein is not a major neutralization or protective antigen. Also, although the SH protein of HMPV is a virion protein that is much larger than its counterparts in previously studied paramyxoviruses, it does not appear to be a significant neutralization or protective antigen.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16300813     DOI: 10.1016/j.virol.2005.10.016

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  41 in total

Review 1.  Nonsegmented negative-strand viruses as vaccine vectors.

Authors:  Alexander Bukreyev; Mario H Skiadopoulos; Brian R Murphy; Peter L Collins
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

Review 2.  Recent vaccine development for human metapneumovirus.

Authors:  J Ren; T Phan; X Bao
Journal:  J Gen Virol       Date:  2015-02-09       Impact factor: 3.891

Review 3.  New Approaches for Immunization and Therapy against Human Metapneumovirus.

Authors:  Sherry C Wen; John V Williams
Journal:  Clin Vaccine Immunol       Date:  2015-06-10

Review 4.  Modulation of Host Immunity by the Human Metapneumovirus.

Authors:  Pablo F Céspedes; Christian E Palavecino; Alexis M Kalergis; Susan M Bueno
Journal:  Clin Microbiol Rev       Date:  2016-10       Impact factor: 26.132

5.  Serologic cross-reactions between nucleocapsid proteins of human respiratory syncytial virus and human metapneumovirus.

Authors:  Yange Zhang; Jan Pohl; W Abdullah Brooks; Dean D Erdman
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

6.  Frequent frameshift and point mutations in the SH gene of human metapneumovirus passaged in vitro.

Authors:  Stéphane Biacchesi; Brian R Murphy; Peter L Collins; Ursula J Buchholz
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

7.  Human metapneumovirus G protein is highly conserved within but not between genetic lineages.

Authors:  Chin-Fen Yang; Chiaoyin K Wang; Sharon J Tollefson; Linda D Lintao; Alexis Liem; Marla Chu; John V Williams
Journal:  Arch Virol       Date:  2013-02-06       Impact factor: 2.574

8.  Population-based incidence of human metapneumovirus infection among hospitalized children.

Authors:  John V Williams; Kathryn M Edwards; Geoffrey A Weinberg; Marie R Griffin; Caroline B Hall; Yuwei Zhu; Peter G Szilagyi; Chiaoyin K Wang; Chin-Fen Yang; David Silva; Dan Ye; Richard R Spaete; James E Crowe
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

9.  An alphavirus replicon-based human metapneumovirus vaccine is immunogenic and protective in mice and cotton rats.

Authors:  Hoyin Mok; Sharon J Tollefson; Amy B Podsiad; Bryan E Shepherd; Vasiliy V Polosukhin; Robert E Johnston; John V Williams; James E Crowe
Journal:  J Virol       Date:  2008-09-10       Impact factor: 5.103

10.  Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years.

Authors:  Chin-Fen Yang; Chiaoyin K Wang; Sharon J Tollefson; Rohith Piyaratna; Linda D Lintao; Marla Chu; Alexis Liem; Mary Mark; Richard R Spaete; James E Crowe; John V Williams
Journal:  Virol J       Date:  2009-09-09       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.